William Mack & Associates’s Boston Scientific BSX Stock Holding History

William Mack & Associates’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.48K	Buy	+34	New	+$1.57K	﹤0.01%	613

Other funds holding BSX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

William Mack & Associates's BSX Position: Q3 2026 in Review

William Mack & Associates opened a new position in Boston Scientific (BSX) in Q3 2026: 34 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #613 among its holdings.

1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

William Mack & Associates held 34 shares of Boston Scientific worth $1.48K as of Q3 2026.
Boston Scientific was a new William Mack & Associates position in Q3 2026.
Boston Scientific made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #613 holding.
1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.